Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 2:57 pm Purchase |
2024-09-30 | 13G | Ascendis Pharma A/S ASND |
JANUS HENDERSON GROUP PLC JHG |
4,186,694 7.000% |
191,909 (+4.80%) |
Filing History |
| 2024-11-14 2:55 pm Sale |
2024-09-30 | 13G | Ziff Davis, Inc. ZD |
JANUS HENDERSON GROUP PLC JHG |
3,214,600 7.200% |
-14,751 (-0.46%) |
Filing History |
| 2024-11-14 2:54 pm Sale |
2024-09-30 | 13G | OSI Systems, Inc. OSIS |
JANUS HENDERSON GROUP PLC JHG |
1,209,168 7.300% |
-21,038 (-1.71%) |
Filing History |
| 2024-11-14 2:53 pm Purchase |
2024-09-30 | 13G | Vaxcyte, Inc. PCVX |
JANUS HENDERSON GROUP PLC JHG |
10,921,896 9.800% |
3,940,520 (+56.44%) |
Filing History |
| 2024-11-14 1:37 pm Sale |
2024-09-30 | 13G | Benitec Biopharma Inc. BNTC |
JANUS HENDERSON GROUP PLC JHG |
876,523 8.300% |
-1,805,752 (-67.32%) |
Filing History |
| 2024-11-14 1:35 pm Purchase |
2024-09-30 | 13G | Applied Therapeutics, Inc. APLT |
JANUS HENDERSON GROUP PLC JHG |
10,541,528 9.200% |
4,126,886 (+64.34%) |
Filing History |
| 2024-11-14 1:34 pm Purchase |
2024-09-30 | 13G | Precision BioSciences, Inc. DTIL |
JANUS HENDERSON GROUP PLC JHG |
702,069 9.700% |
190,961 (+37.36%) |
Filing History |
| 2024-11-14 12:55 pm Sale |
2024-09-30 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
JANUS HENDERSON GROUP PLC JHG |
4,480,284 9.400% |
-508,463 (-10.19%) |
Filing History |
| 2024-11-14 12:51 pm Sale |
2024-09-30 | 13G | Soleno Therapeutics, Inc. SLNO |
JANUS HENDERSON GROUP PLC JHG |
4,081,099 10.500% |
-82,579 (-1.98%) |
Filing History |
| 2024-11-14 12:47 pm Purchase |
2024-09-30 | 13G | 89bio, Inc. ETNB |
JANUS HENDERSON GROUP PLC JHG |
15,158,218 14.300% |
5,076,960 (+50.36%) |
Filing History |
| 2024-11-14 12:39 pm Unchanged |
2024-09-30 | 13G | Tenax Therapeutics, Inc. TENX |
JANUS HENDERSON GROUP PLC JHG |
359,848 10.000% |
0 (Unchanged) |
Filing History |
| 2024-11-14 12:32 pm Purchase |
2024-09-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
JANUS HENDERSON GROUP PLC JHG |
3,763,195 11.400% |
369,908 (+10.90%) |
Filing History |
| 2024-11-14 12:30 pm Sale |
2024-09-30 | 13G | Immunic, Inc. IMUX |
JANUS HENDERSON GROUP PLC JHG |
5,099,278 5.700% |
-1,593,729 (-23.81%) |
Filing History |
| 2024-11-14 12:28 pm Purchase |
2024-09-30 | 13G | CytomX Therapeutics, Inc. CTMX |
JANUS HENDERSON GROUP PLC JHG |
4,809,518 6.200% |
651,408 (+15.67%) |
Filing History |
| 2024-11-14 11:50 am Purchase |
2024-09-30 | 13G | Avadel Pharmaceuticals plc AVDL |
JANUS HENDERSON GROUP PLC JHG |
13,326,887 13.800% |
13,326,887 (New Position) |
Filing History |
| 2024-11-14 11:49 am Purchase |
2024-09-30 | 13G | Consensus Cloud Solutions, Inc. CCSI |
JANUS HENDERSON GROUP PLC JHG |
2,380,874 12.300% |
234,008 (+10.90%) |
Filing History |
| 2024-11-14 11:44 am Purchase |
2024-09-30 | 13G | Mereo BioPharma Group plc MREO |
JANUS HENDERSON GROUP PLC JHG |
12,345,866 8.000% |
4,400,162 (+55.38%) |
Filing History |
| 2024-11-14 11:41 am Purchase |
2024-09-30 | 13G | Larimar Therapeutics, Inc. LRMR |
JANUS HENDERSON GROUP PLC JHG |
5,566,855 8.700% |
2,925,790 (+110.78%) |
Filing History |
| 2024-11-14 11:38 am Sale |
2024-09-30 | 13G | ICU Medical, Inc. ICUI |
JANUS HENDERSON GROUP PLC JHG |
2,411,638 9.900% |
-206,295 (-7.88%) |
Filing History |
| 2024-11-14 11:36 am Purchase |
2024-09-30 | 13G | WEX Inc. WEX |
JANUS HENDERSON GROUP PLC JHG |
4,163,678 10.100% |
12,883 (+0.31%) |
Filing History |